Fibrosis research: Advances and challenges
Drug Discovery World
JANUARY 24, 2024
Fibrocor Therapeutics, a developer of novel therapeutics to treat fibrosis, recently appointed Piet Wigerinck as Chief Scientific Advisor. This has hindered development of drugs so that, from a therapeutic intervention point of view, fibrosis research is still in its infancy. That part of the program looks easy.
Let's personalize your content